in it to win it

InnovationMap reveals the winners of our inaugural awards

The inaugural InnovationMap Awards revealed its big winners across eight categories and honored its Trailblazer Award recipient. Photos courtesy

The votes are in — and it's time to announce the winners of the inaugural InnovationMap Awards, presented by Techwave.

The event, held September 8 at The Cannon, honored all 28 finalists, spanning innovative Houston companies and founders, as well as our first-ever Trailblazer Award recipient, Barbara Burger. Click here to read about all the finalists.

Eight judges evaluated over 100 applications across eight categories for the 2021 InnovationMap Awards presented by Techwave. This year's judges included: Juliana Garaizar, head of the Houston incubator and vice president of innovation at Greentown Labs; Alex Gras, managing director at The Cannon; Rajasekhar Gummadapu, co-founder and CEO of Techwave; Natalie Harms, editor of InnovationMap; Serafina Lalany, interim president at Houston Exponential; Jon Nordby, managing director at MassChallenge; Emily Reiser, senior manager of innovation community engagement at the Texas Medical Center; and Grace Rodriguez, CEO and executive director of Impact Hub Houston.

Want to watch the event in full? Click here.

Without further adieu, here are our 2021 InnovationMap Award winners.

Hello Alice is a small business owner's passport through entrepreneurship that helps with networking, raising capital, and accessing growth tools. The company was also nominated for the People's Choice: Startup of the Year Award and the Female-Founded Business categories.

Topl is an impact monetization engine that enables digital and sustainable transformation across value chains and empowers the monetization of impact verified on the Topl Blockchain. The company was also nominated for the People's Choice: Startup of the Year Award.

Saranas is the creator of the Early Bird, the first and only FDA-approved bleed detection system for endovascular procedures.

Nanotech is a material science company with a mission to fireproof the world and reduce energy consumption. Nanotech was also a finalist for the People's Choice category.

Mainline is an esports tournament management system, tournament organizer, and event production company.

Cemvita Factory — engineering microbes that eat CO2 and produce valuable chemicals. The company was also a finalist in the Energy Transition Business category.

Kim Roxie of LAMIK Beauty — a tech-enabled clean color cosmetics company focusing on women of all diverse backgrounds. LAMIK was also a finalist in the BIPOC-Founded Business category,

The inaugural InnovationMap Awards event, which is about three weeks away, was created to honor the best of Houston innovation. The Trailblazer Award in particular was established to honor a Houston innovation leader and advocate who's making a lasting impact on the Houston innovation community.

Barbara Burger, vice president of innovation at Chevron and president of Chevron Technology Ventures, was selected to receive the 2021 Trailblazer Award at the InnovationMap Awards presented by Techwave. Burger was nominated and approved by this year's judges. Click here to read more about the Trailblazer Award.

And the winner is.... Cheers Health, which is creating products that are designed to support your liver and help you feel better after consuming alcohol.

Trending News

Building Houston

 
 

Optellum, which has its United States operations based in the TMC Innovation Institute, has raised fresh funding. Photo via Getty Images

A Oxford-based health tech startup that has its United States headquarters in Houston has announced the close of its series A round of funding.

Optellum, which has created a breakthrough AI platform to diagnose and treat early-stage lung cancer, has raised $14 million in a series A funding round. The round was led by United Kingdom-based Mercia, with additional investors California-based Intuitive Ventures and New York-based Black Opal Ventures. Existing investors, including St John's College in the University of Oxford, IQ Capital, and the family office of Sir Martin & Lady Audrey Wood, also participated in the round, per a news release.

"Lung cancer is an urgent public health crisis and Optellum's groundbreaking approach utilizing AI to accelerate early detection and intervention may fundamentally alter the healthcare community's approach to combating this disease," says Dr. Oliver Keown, managing director of Intuitive Ventures, in the release. "Optellum is uniquely positioned to align and provide considerable value to patients, providers, and payers alike. Intuitive Ventures is thrilled to provide our full arsenal of financial and strategic support to Optellum as we work towards a world of better outcomes for cancer patients."

The fresh funding will go toward scaling Optellum's operations and commercial launches in the United Kingdom and in the United States. Additionally, the company plans to expand its platform, including providing personalized therapy support using imaging data with molecular data, robotics, and liquid biopsies.

"With this strong support and commitment of highly specialized investors, we are positioned to accelerate commercial deployment in both the UK and the United States to expand our installed base," says Jason Pesterfield, CEO at Optellum, in the release. "Following years of research and clinical trials that have shown the impact of our software on the diagnosis of at-risk lung nodules, we're focused on expanding patient access to this crucial technology and identifying deadly lung cancer faster in more at-risk people. The funding will also boost our research and development with world-leading institutions and partners to progress further innovation."

Optellum's software provides support for physicians making decisions in early lung cancer diagnosis and treatment. The company was launched to provide better diagnostics and early-stage treatment to increase survival rates and improve health outcomes.

Last year, Optellum — whose U.S. headquarters is at Houston's TMC Innovation Institute — announced it would be included in J&J's Lung Cancer Initiative. The startup was a 2019 graduate of the Texas Medical Center's accelerator and its software platform, Virtual Nodule Clinic, received FDA clearance, CE-MDR in the EU, and UKCA in the UK.

"Optellum is the latest in a series of companies to channel research from the UK's world-leading universities into commercially viable products that can make a difference to the provision of medical care," says Mercia Investment Director Stephen Johnson in the release. "Having observed Optellum achieve great milestones over the years, we are now excited to become part of their success and apply our experience with scaling up software and deep-tech companies to help accelerate Optellum's impact on patient lives across the world."

Trending News